Skip to main content

Written question asked by Paul Burstow (Liberal Democrat) on Monday, 17 November 2003, in the House of Commons. It was due for an answer on Thursday, 20 November 2003. It was answered by Stephen Ladyman (Labour) on Thursday, 20 November 2003 on behalf of the Department of Health.


Dept of Health

Question
To ask the Secretary of State for Health, what assessment he has made of the availability of the anti-dementia drug Ebixa.
Answer

Mr. Burstow: To ask the Secretary of State for Health what assessment he has made of the availability of the anti-dementia drug Ebixa. [140111] Dr. Ladyman: The National Institute for Clinical Excellence (NICE) will appraise Memantine (Ebixa), for the treatment of moderate to severe dementia, as part of the eighth wave of its work programme. The anticipated publication date of its recommendations is May 2005. Until NICE has made its recommendations it is for local areas to make decisions about availability on the national health service having taken account of published evidence.


Secondary information

Type
Written question
Reference
140111; 413 c1374W;413 c1370W
Session
2002-03
Subjects
Dementia Drugs
Link
View this Written question on www.publications.parliament.uk